Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Head & Neck|January 29, 2014
Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statementMaisie L Shindo, Salvatore M Caruana, Emad Kandil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancerDavid M Jackman, Beow Y Yeap, Neal I Lindeman, et al.
Journal of Palliative Medicine|September 6, 2019
Early Integrated Telehealth versus In-Person Palliative Care for Patients with Advanced Lung Cancer: A Study ProtocolIsaac S Chua, Finly Zachariah, William Dale, et al.
Oral Oncology|October 14, 2023
Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV studySana Batool, Rosh K V Sethi, Annette Wang, et al.
Scientific Reports|November 20, 2020
LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilageMustafa M Tashkandi, Saqer F Alsaqer, Thabet Alhousami, et al.
Breast Cancer Research and Treatment|April 20, 2022
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)Elizabeth O'Donnell, Yael Shapiro, Amy Comander, et al.
BMC Oral Health|May 18, 2021
A preliminary assessment of guideline adherence and clinical variation in oral cancer treatment: a MarketScan database studyAntoine Eskander, Axel Sahovaler, Jennifer Shin, et al.
Molecular Cancer Research : MCR|February 2, 2022
Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ InhibitionThabet Alhousami, Michael Diny, Faiza Ali, et al.
Science Translational Medicine|March 25, 2011
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitorsLecia V Sequist, Belinda A Waltman, Dora Dias-Santagata, et al.
Breast Cancer Research and Treatment|September 17, 2018
Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancerLaura Spring, Andrzej Niemierko, Stephanie Haddad, et al.
Pageof 8